Vir Gets FDA Breakthrough Therapy Status for Two Drugs

Seeking Alpha17:03 ET

Thursday Ends in Index Declines | Wall Street Today

Kevin Travers16:29 ET

Gilead Unveils New Yearly HIV Injection To Offer Hope for Less Frequent Preventive Dosing

Benzinga13:13 ET

Market Falls Thursday, Producer Inflation Grows, and Tech Pulls Back From Records | LiveStock

Kevin Travers11:21 ET

Natera Announces Enrollment Of First Patients In SAGITTARIUS A Randomized Phase III Clinical Trial In Colon Cancer; ~700-900 Patients Expected To Be Enrolled Across More Than 20 Sites

BenzingaDec 12 08:06 ET

$1000 Invested In United Therapeutics 20 Years Ago Would Be Worth This Much Today

BenzingaDec 11 16:00 ET